AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 265 filers reported holding AVANOS MED INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $330,000 | -84.7% | 12,073 | -81.2% | 0.00% | -75.0% |
Q1 2022 | $2,151,000 | +5.1% | 64,200 | +8.8% | 0.00% | 0.0% |
Q4 2021 | $2,046,000 | +11.1% | 59,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,841,000 | -14.2% | 59,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $2,146,000 | -16.9% | 59,000 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $2,581,000 | -4.7% | 59,000 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $2,707,000 | +22.7% | 59,000 | -11.1% | 0.01% | 0.0% |
Q3 2020 | $2,206,000 | +12.9% | 66,400 | -0.2% | 0.01% | +20.0% |
Q2 2020 | $1,954,000 | +9.3% | 66,500 | +0.2% | 0.01% | -16.7% |
Q1 2020 | $1,788,000 | -20.1% | 66,400 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $2,238,000 | -10.0% | 66,400 | 0.0% | 0.01% | -14.3% |
Q3 2019 | $2,487,000 | -14.1% | 66,400 | 0.0% | 0.01% | -12.5% |
Q2 2019 | $2,896,000 | +4.5% | 66,400 | +2.3% | 0.01% | 0.0% |
Q1 2019 | $2,770,000 | +23.7% | 64,900 | +29.8% | 0.01% | +14.3% |
Q4 2018 | $2,239,000 | -34.6% | 50,000 | 0.0% | 0.01% | -22.2% |
Q3 2018 | $3,425,000 | – | 50,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |